Literature DB >> 19856220

Clinicopathological features from long-term observation of a papillary tumor of the pineal region (PTPR): a case report.

Hirohito Yano1, Naoyuki Ohe, Noriyuki Nakayama, Jun Shinoda, Toru Iwama.   

Abstract

Papillary tumor of the pineal region (PTPR) was recently added to the 2007 WHO classification of tumors of the central nervous system as a rare pineal tumor. We present a case of a 17-year-old man who developed a 3-cm pineal tumor that was incompletely excised following two operations. The pathological findings presented were extensive epithelial papillary structures surrounding vessels mimicking "perivascular pseudo-rosettes," leading to a diagnosis of "papillary ependymoma." Subsequently, the residual tumor recurred on three separate occasions. Immunohistochemical studies showed the tumor was positive for cytokeratin 18 (CK 18), microtubule-associated protein (MAP 2), neuron-specific enolase (NSE), neuronal nuclei (NeuN), and transthyretin, consistent with mature neuronal differentiation. Given these findings, the diagnosis of PTPR was made. The patient's survival time of 218 months is the longest reported to date for this tumor.

Entities:  

Mesh:

Year:  2009        PMID: 19856220     DOI: 10.1007/s10014-009-0246-z

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  3 in total

1.  Natural history of papillary tumor of the pineal region: new insights on biological explanation.

Authors:  Gentian Kaloshi; Arben Rroji; Artid Lame; Llambi Leka; Eduard Haxhihyseni; Gjergji Vreto; Mentor Petrela
Journal:  J Neurooncol       Date:  2010-05-08       Impact factor: 4.130

2.  Cellular pleomorphism in papillary tumors of the pineal region.

Authors:  Juliana Magalhães; Steven Rostad; Greg Foltz; Peter Pytel; Fausto J Rodriguez
Journal:  Brain Tumor Pathol       Date:  2012-05-24       Impact factor: 3.298

3.  Role of surgery, radiotherapy and chemotherapy in papillary tumors of the pineal region: a multicenter study.

Authors:  F Fauchon; M Hasselblatt; A Jouvet; J Champier; M Popovic; R Kirollos; T Santarius; S Amemiya; T Kumabe; D Frappaz; M Lonjon; M Fèvre Montange; A Vasiljevic
Journal:  J Neurooncol       Date:  2013-01-12       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.